These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 4735426)
1. Immunoreactive calcitonin in medullary carcinoma of the thyroid and in maternal and cord serum. Samaan NA; Hill CS; Beceiro JR; Schultz PN J Lab Clin Med; 1973 May; 81(5):671-81. PubMed ID: 4735426 [No Abstract] [Full Text] [Related]
2. [Calcitonin and its significance for the diagnosis of medullary carcinoma of the thyroid]. Gautvik KM Tidsskr Nor Laegeforen; 1973 May; 93(15):1143-8. PubMed ID: 4584540 [No Abstract] [Full Text] [Related]
3. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma. Goltzman D; Potts JT; Ridgway RC; Maloof F N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025 [No Abstract] [Full Text] [Related]
4. Immunoassay of human calcitonin. Tashijan AH; Howland BG; Melvin KE; Hill CS N Engl J Med; 1970 Oct; 283(17):890-5. PubMed ID: 5458052 [No Abstract] [Full Text] [Related]
5. Diagnostic dependability of calcitonin assay in family studies for medullary thyroid carcinoma. Jackson CE; Tashjian AH; Block MA J Lab Clin Med; 1971 Nov; 78(5):817-8. PubMed ID: 5128860 [No Abstract] [Full Text] [Related]
6. Radioimmunoassay of human plasma calcitonin. Frölich M; Kassenaar AA; Smeenk D Horm Metab Res; 1971 Jul; 3(4):297-8. PubMed ID: 5167036 [No Abstract] [Full Text] [Related]
7. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland. Linehan WM; Farrell RE; Cooper CW; Wells SA Surg Forum; 1977; 28():110-2. PubMed ID: 617389 [No Abstract] [Full Text] [Related]
8. Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid. Sizemore GW; Go VL; Kaplan EL; Sanzenbacher LJ; Holtermuller KH; Arnaud CD N Engl J Med; 1973 Mar; 288(13):641-4. PubMed ID: 4734496 [No Abstract] [Full Text] [Related]
9. Application of non-commercial methods for estimation of immunoreactive serum calcitonin in clinical practice (comparison of two methods). Bednár J; Neradilová M; Soutorová M; Bílek R; Nĕmec J; Pechová M; Havelka J Czech Med; 1991; 14(4):205-12. PubMed ID: 1842705 [TBL] [Abstract][Full Text] [Related]
10. Calcitonin secretion in medullary carcinoma of the thyroid. Frölich M; Heersche JN; Lemkes HH; Thesingh CW Horm Metab Res; 1972 Sep; 4(5):407. PubMed ID: 4345756 [No Abstract] [Full Text] [Related]
11. Combining provocative agents of calcitonin to detect medullary carcinoma of the thyroid. Sisson JC; Gross MD; Frietas JE; Jackson CE; England BG Henry Ford Hosp Med J; 1981; 29(2):75-80. PubMed ID: 7263287 [No Abstract] [Full Text] [Related]
12. Serum calcitonin in medullary thyroid carcinoma. Radioimmunoassay technique and diagnostic value. Almqvist S; Telenius-Berg M; Wästhed B Acta Med Scand; 1974 Sep; 196(3):177-80. PubMed ID: 4472910 [No Abstract] [Full Text] [Related]
13. [Calcitonin as a tumor marker. I. Medullary carcinoma of the thyroid]. Galán Galán F; Garrido Peralta M Rev Clin Esp; 1982 Apr; 165(1):5-9. PubMed ID: 7122936 [No Abstract] [Full Text] [Related]
14. [Medullary cancer of the thyroid and hyperthyrocalcitonin syndrome]. Milhaud G; Coutris G; Tubiana M Presse Med (1893); 1969 Dec; 77(56):2129-32. PubMed ID: 5374252 [No Abstract] [Full Text] [Related]